Blue Trust Inc’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.22K Hold
86
﹤0.01% 1886
2026
Q1
$680 Sell
86
-1
-1% -$16 ﹤0.01% 2308
2025
Q4
$1.5K Hold
87
﹤0.01% 2196
2025
Q3
$2.24K Hold
87
﹤0.01% 2136
2025
Q2
$5K Hold
87
﹤0.01% 2004
2025
Q1
$9.41K Hold
87
﹤0.01% 1915
2024
Q4
$4.13K Sell
87
-7
-7% -$423 ﹤0.01% 2121
2024
Q3
$15.3K Buy
94
+7
+8% +$904 ﹤0.01% 2050
2024
Q2
$13.3K Hold
87
﹤0.01% 1829
2024
Q1
$13.3K Hold
87
﹤0.01% 1372
2023
Q4
$39K Hold
87
﹤0.01% 1014
2023
Q3
$38K Buy
+87
New +$39.3K ﹤0.01% 936
2023
Q2
Sell
-1
Closed 1999
2023
Q1
$0 Buy
+1
New +$560 ﹤0.01% 2275

Other funds holding AGL

Blue Trust Inc's AGL Position: Q2 2026 in Review

Blue Trust Inc held its Agilon Health (AGL) position steady in Q2 2026 at 86 shares worth $9.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1886.

Blue Trust Inc first reported a position in AGL in Q1 2023 and has held it in 13 quarters since. The position peaked at $39K in Q4 2023. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Blue Trust Inc held 86 shares of Agilon Health worth $9.22K as of Q2 2026.
  • Blue Trust Inc left its Agilon Health share count unchanged in Q2 2026.
  • Agilon Health made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1886 holding.
  • Blue Trust Inc first reported a position in Agilon Health in Q1 2023 and has held it in 13 quarters since.
  • Blue Trust Inc's Agilon Health position peaked at $39K in Q4 2023.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.